Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
6.00
-0.09 (-1.48%)
Feb 13, 2026, 4:08 PM HKT
HKG:1167 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 993.79 | 1,175 | 1,148 | 1,299 | 1,538 | 1,627 |
Cash & Short-Term Investments | 993.79 | 1,175 | 1,148 | 1,299 | 1,538 | 1,627 |
Cash Growth | -6.26% | 2.33% | -11.62% | -15.54% | -5.52% | 417.73% |
Accounts Receivable | 50.56 | 7.68 | 9.34 | 15.03 | 64.92 | 171.41 |
Other Receivables | 6.94 | 0.85 | 3.46 | 25.03 | 32.68 | 15.74 |
Receivables | 57.51 | 8.53 | 12.8 | 40.06 | 97.59 | 187.16 |
Inventory | - | 3.89 | 6.2 | - | - | - |
Other Current Assets | 80.31 | 1.66 | 1.57 | - | 4.55 | 0.78 |
Total Current Assets | 1,132 | 1,189 | 1,168 | 1,339 | 1,640 | 1,815 |
Property, Plant & Equipment | 140.33 | 151.49 | 219.6 | 205.23 | 41.77 | 34.13 |
Long-Term Investments | 18.09 | 18.16 | 68.19 | 25.42 | 16.23 | - |
Other Intangible Assets | 1.23 | 0.84 | 1.37 | 1.02 | 1.55 | 1.17 |
Long-Term Accounts Receivable | - | 0.06 | 2.91 | - | - | - |
Other Long-Term Assets | - | - | - | 4.23 | 22.56 | 16.7 |
Total Assets | 1,291 | 1,359 | 1,460 | 1,575 | 1,722 | 1,867 |
Accounts Payable | - | 117.96 | 81.19 | 96.55 | 51.05 | 28.28 |
Accrued Expenses | - | 7.56 | 17.96 | 25.4 | 19.15 | 14.59 |
Short-Term Debt | - | - | 73.62 | - | - | - |
Current Portion of Long-Term Debt | 82.21 | 56.06 | - | - | - | - |
Current Portion of Leases | 9.83 | 9.9 | 14.33 | 13.13 | 4.92 | 8.64 |
Current Income Taxes Payable | - | 1.04 | 1.94 | 2.35 | 1.97 | 1.73 |
Other Current Liabilities | 58.25 | 50.33 | 16.1 | 18.42 | 3.75 | 20.64 |
Total Current Liabilities | 150.28 | 242.85 | 205.13 | 155.85 | 80.83 | 73.88 |
Long-Term Debt | 52.09 | 16 | - | - | - | - |
Long-Term Leases | 65.25 | 70.12 | 121.97 | 134.66 | 1.89 | 2.01 |
Long-Term Unearned Revenue | 0.67 | 0.78 | 1.19 | 1.61 | 2.02 | 5.26 |
Other Long-Term Liabilities | 155.58 | 106.24 | 58.82 | - | - | - |
Total Liabilities | 423.87 | 435.99 | 387.11 | 292.12 | 84.75 | 81.15 |
Common Stock | 0.52 | 0.52 | 0.52 | 0.51 | 0.51 | 0.5 |
Retained Earnings | -3,409 | -3,350 | -3,194 | -2,835 | -2,463 | -2,162 |
Treasury Stock | -4.81 | -4.57 | - | - | - | - |
Comprehensive Income & Other | 4,280 | 4,277 | 4,267 | 4,117 | 4,099 | 3,947 |
Total Common Equity | 867.38 | 923.18 | 1,073 | 1,283 | 1,637 | 1,786 |
Shareholders' Equity | 867.38 | 923.18 | 1,073 | 1,283 | 1,637 | 1,786 |
Total Liabilities & Equity | 1,291 | 1,359 | 1,460 | 1,575 | 1,722 | 1,867 |
Total Debt | 209.37 | 152.08 | 209.91 | 147.79 | 6.81 | 10.65 |
Net Cash (Debt) | 784.42 | 1,022 | 937.93 | 1,151 | 1,531 | 1,617 |
Net Cash Growth | -9.00% | 9.01% | -18.50% | -24.82% | -5.32% | 474.68% |
Net Cash Per Share | 1.01 | 1.32 | 1.21 | 1.53 | 2.05 | 4.24 |
Filing Date Shares Outstanding | 788.74 | 788.82 | 791.76 | 771.46 | 771.46 | 759.65 |
Total Common Shares Outstanding | 788.74 | 788.82 | 791.76 | 771.46 | 771.46 | 759.65 |
Working Capital | 981.32 | 945.77 | 963.28 | 1,183 | 1,559 | 1,741 |
Book Value Per Share | 1.10 | 1.17 | 1.36 | 1.66 | 2.12 | 2.35 |
Tangible Book Value | 866.15 | 922.34 | 1,072 | 1,282 | 1,636 | 1,785 |
Tangible Book Value Per Share | 1.10 | 1.17 | 1.35 | 1.66 | 2.12 | 2.35 |
Machinery | - | 57.83 | 59.38 | 53.3 | 50.03 | 42.14 |
Construction In Progress | - | - | - | 27.79 | - | - |
Leasehold Improvements | - | 62.1 | 61.86 | 10.2 | 10.2 | 8.02 |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.